STOCK TITAN

GENFIT (GNFT) 6-K folds September 22, 2025 press release into F-3 and S-8

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

GENFIT S.A. furnished a Form 6-K as a foreign private issuer, mainly to attach a press release dated September 22, 2025 as Exhibit 99.1. The company also made this report part of its existing Form F-3 and Form S-8 registration statements by incorporating it by reference. The filing was signed by Chief Executive Officer Pascal Prigent.

Positive

  • None.

Negative

  • None.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

Date of report: September 22, 2025

 

Commission File Number: 001-38844

 

GENFIT S.A.

(Translation of registrant’s name into English)

 

Parc Eurasanté

885, avenue Eugène Avinée

59120 Loos, France

 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

☒ Form 20-F  ☐ Form 40-F

 

 

 

 

 

INCORPORATION BY REFERENCE

  

 

The contents of this report on Form 6-K (including Exhibit 99.1) are hereby incorporated by reference into the registrant’s registration statement on Form F-3 (File No. 333-271312) and registration statement on Form S-8 (File No. 333-271311) and related prospectuses, as such registration statements and prospectuses may be amended from time to time, and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. Information contained on, or that can be accessed through, any website included in Exhibit 99.1 is expressly not incorporated by reference

 

 

 

 

 

 

 

 

EXHIBIT LIST

 

     

Exhibit

 

Description

   
99.1   Press Release dated September 22, 2025.
   
     
   
     

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

             
        GENFIT S.A.
       
Date: September 22, 2025       By:   /s/ Pascal PRIGENT
            Name: Pascal PRIGENT
            Title: Chief Executive Officer

 

 

FAQ

What did GENFIT (GNFT) file in this Form 6-K?

GENFIT filed a Form 6-K as a foreign private issuer to furnish a press release dated September 22, 2025 as Exhibit 99.1. The report mainly serves as an informational update rather than a detailed financial disclosure.

How does this GENFIT (GNFT) Form 6-K affect its existing registrations?

The Form 6-K is incorporated by reference into GENFIT’s existing Form F-3 and Form S-8 registration statements, including their related prospectuses. This means the information in the report becomes legally part of those registrations for securities purposes.

What is included as Exhibit 99.1 in GENFIT’s (GNFT) Form 6-K?

Exhibit 99.1 is a press release dated September 22, 2025. While the content of the press release is not detailed here, the exhibit is formally attached to and furnished through this Form 6-K filing.

Who signed GENFIT’s (GNFT) September 22, 2025 Form 6-K?

The Form 6-K was signed on behalf of GENFIT S.A. by Pascal Prigent, the company’s Chief Executive Officer. His signature confirms the company’s authorization and responsibility for the information furnished in the report.

Are GENFIT’s (GNFT) website materials part of this Form 6-K?

Information on or accessible through any website mentioned in Exhibit 99.1 is expressly not incorporated by reference. Only the specific contents of the Form 6-K and its exhibit are included in the company’s registration statements.
Genfit S.A.

NASDAQ:GNFT

View GNFT Stock Overview

GNFT Rankings

GNFT Latest News

GNFT Latest SEC Filings

GNFT Stock Data

242.51M
50.00M
Biotechnology
Healthcare
Link
France
Loos